PNT
POINT Biopharma Global Inc. Common Stock
Delisted
PNT was delisted on the 26th of December, 2023.
28 hedge funds and large institutions have $149M invested in POINT Biopharma Global Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
28
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$11.3M | |
| 2 | +$7.36M | |
| 3 | +$3.94M | |
| 4 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$2.72M |
| 5 |
JGC
J. Goldman & Co
New York
|
+$1.79M |
Top Sellers
| 1 | -$12.9M | |
| 2 | -$5.57M | |
| 3 | -$1.92M | |
| 4 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$687K |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$658K |